Michael Hayden

Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) announced on Tuesday it has entered into a new collaborative research agreement with AbCellera, a privately held company that has developed a high-throughput platform for the rapid discovery of therapeutic antibodies directly from natural immune...

In a report published Wednesday, BMO Capital Markets analyst David Maris discussed key takeaways from a day of meetings with several specialty pharmaceutical companies. Below are some of the highlights of notable presentations. Allergan PLC (NYSE: AGN): The company is planning to work...

A new report by security experts confirms what people involved with the nation's infrastructure have suspected for some time: that America's energy sectors are still very vulnerable to a massive and potentially crippling cyber attack. The report, by the Bipartisan Policy Center in Washington,...